文献速递膀胱癌与上尿路尿路上皮癌

转移性膀胱癌的转移位置决定根治性膀胱切除术后的院内死亡率

Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy.
PubMed 文献 · Eur Urol Oncol · 2018-05-15

基于美国全国住院患者样本数据库1998至2013年25004例接受根治性膀胱切除术的膀胱癌患者,分析转移部位与院内死亡率的关系。多变量分析显示,远处转移与院内死亡率升高相关(OR 2.31,95%CI 1.57-3.28;p<0.001),而非区域淋巴结转移与院内死亡率无显著关联(OR 0.88,95%CI 0.66-1.15;p=0.4)。作者认为,若有指征,转移性膀胱癌的根治性膀胱切除术应仅限于非区域淋巴结转移患者。

要点

  • 25004例接受根治性膀胱切除术的患者中,14.4%有非区域淋巴结转移,2.8%有远处转移。
  • 远处转移与院内死亡率升高相关(OR 2.31,95%CI 1.57-3.28;p<0.001)。
  • 非区域淋巴结转移与院内死亡率无显著关联(OR 0.88,95%CI 0.66-1.15;p=0.4)。

核心结论

  • 高度选择性的非区域淋巴结转移患者接受根治性膀胱切除术后,院内死亡风险与非转移性膀胱癌患者相似。
  • 远处转移患者相比非区域淋巴结转移患者,院内死亡风险更高。

研究设计与样本

  • 回顾性研究,使用1998至2013年美国全国住院患者样本数据库中的25004例膀胱癌患者数据。
  • 干预为根治性膀胱切除术。
  • 多变量逻辑回归分析校正了年龄、性别、种族、合并症、住院时间、医院位置、教学状态、医院手术量和床位规模。

主要发现

  • 25004例接受根治性膀胱切除术的患者中,3830例(14.4%)有非区域淋巴结转移,693例(2.8%)有远处转移,19965例(79.8%)无转移。
  • 转移性膀胱癌患者中,几乎均为单个转移灶(n=4020;93.7%)。
  • 多变量逻辑回归分析中,远处转移与院内死亡率升高相关(OR 2.31,95%CI 1.57-3.28;p<0.001)。
  • 非区域淋巴结转移与院内死亡率无显著关联(OR 0.88,95%CI 0.66-1.15;p=0.4)。

临床怎么用

  • 作者认为,根据现有数据,若确有指征,转移性膀胱癌的根治性膀胱切除术应仅限于非区域淋巴结转移患者。

局限性

  • 缺乏术前化疗信息可能限制本研究发现。
  • 回顾性研究设计可能限制本研究发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A recent study of a highly select cohort suggested a survival benefit when local treatment is delivered in patients with metastatic bladder cancer (BCa). OBJECTIVE: We examined in-hospital mortality (IHM) rates according to the presence, absence, and location of metastatic disease in a similar highly select cohort of BCa patients treated with radical cystectomy (RC). DESIGN, SETTING, AND PARTICIPANTS: We used data for 25 004 BCa patients included in the National Inpatients Sample (NIS) database between 1998 and 2013. INTERVENTION: Radical cystectomy. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We tested postoperative IHM rates according to the presence of metastases and the location of metastatic disease (exclusive nodal vs distant metastases). Multivariable logistic regression analyses were adjusted for age, gender, race, comorbidities, length of hospitalization, hospital location, teaching status, hospital surgical volume, and bed size. RESULTS AND LIMITATIONS: Among 25 004 BCa patients treated with RC, 3830 (14.4%) had nonregional lymph node metastases (NRNM), 693 (2.8%) had distant metastases (DM), and 19 965 (79.8%) had nonmetastatic disease. Virtually all patients with metastatic BCa had a single metastatic focus (n=4020; 93.7%). In multivariable logistic regression analyses, DM (odds ratio [OR] 2.31, 95% confidence interval [CI] 1.57-3.28; p<0.001) but not NRNM (OR 0.88, 95% CI 0.66-1.15; p=0.4) was associated with higher risk of IHM. The absence of information on preoperative chemotherapy and the retrospective study design may limit our findings. CONCLUSIONS: The risk of IHM for highly select individuals with NRNM treated with RC is similar to that for patients with nonmetastatic BCa. Conversely, patients with DM are at higher risk of IHM compared to patients with NRNM. PATIENT SUMMARY: According to existing data, radical cystectomy in the metastatic bladder cancer setting should be limited to patients with nonregional lymph node metastases, if at all indicated.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Zaffuto E, Bandini M, Moschini M, et al. Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy. Eur Urol Oncol. 2018. PMID: 31100242. doi:10.1016/j.euo.2018.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。